MAY 14, 2015 1:30 PM PDT

Germline Cancer Genetics in 2015

Speaker

Abstract

Germline cancer genetics became a reality with the cloning of the tumor suppressor gene RB1 for hereditary retinoblastoma in 1986 by Friend and Weinberg. The existence of cancer susceptibility genes had been predicted by Knudson and Strong in the so-called "two-hit" hypothesis that was developed based on observations that there were families in which cancers clustered and occurred at younger ages, more often bilaterally in paired organs or as multiple primary tumors, and far more frequently than they did otherwise in the general population. In 2015 there have been hundreds of cancer susceptibility genes identified. Most code for proteins that are involved in DNA repair or other regulatory processes rather than structural proteins. In classical cancer genetics, individuals with cancer or with a family history of the disease may seek evaluation for the possible presence of a cancer predisposition syndrome. If the gene for that syndrome is known, blood or saliva from a family member most likely to carry a predisposing mutation is submitted for analysis to one of the commercial labs. The best candidate in the family would have had a tumor that is a component of the syndrome diagnosed at an early age, for example. Molecular analysis of the germline can be focused on candidate genes (e.g. MMR genes for Lynch syndrome, PTEN for Cowden's syndrome) or performed as part of a panel of cancer susceptibility genes by NGS now available from a number of commercial laboratories. However, incidental identification of germline mutations may now occur in the process of molecular analysis of tumors performed in order to identify therapeutic targets, in the course of which a mutation in a gene that can confer hereditary predisposition may be found. Separate testing of germline material would be indicated to determine whether or not the identified mutation was acquired, and therefore somatic, or germline, which could have implications not only for the patient but also for the family. For some types of cancer, the presence of an underlying hereditary predisposition can affect treatment recommendations or surveillance for additional primary cancers in survivors as well as family members (BRCA1/2 mutations in hereditary breast or ovarian cancer, TP53 mutations in Li Fraumeni Syndrome and radiation oncogenesis, With current whole exome and whole genome analyses being offered to adults and in the prenatal setting, incidental identification of germline mutations in cancer predisposition genes as incidental findings have been part of discussions by genetics and ethicists. Mutations identified in dominant cancer susceptibility genes are on the list of those that should be disclosed in the statement by the American College of Medical Genetics, though there remains some controversy around this issue.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
MAY 14, 2015 1:30 PM PDT

Germline Cancer Genetics in 2015


Specialty

Antibodies

Virology

Immunology

Research

Dna Sequencing

Personalized Medicine

Clinical Diagnostics

Immunity

Cancer Diagnostics

Immunotherapy

Bioinformatics

Flow Cytometry

Immuno-Oncology

Health

Gene Expression

Geography

Asia33%

Europe33%

Registration Source

Website Visitors100%

Job Title

Student50%

Medical Laboratory Technician50%

Organization

Academic Institution33%

Manufacturer - Other33%


Show Resources
Loading Comments...
Show Resources